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ABSTRACT 
Orotidine 5′-monophosphate decarboxylase (OMPDC) achieves a rarely paralleled rate 
acceleration, yet the catalytic basis prompting this enhancement have yet to be fully elucidated. 
To accomplish decarboxylation, OMPDC must overcome the high energy barrier due to the 
localized anionic charge of the intermediate. Mechanistic studies employing enzyme 
mutagenesis and product or intermediate analogues were used to investigate possible transition 
state stabilization by a carbene resonance structure. Viability of the carbene structure depends 
upon a key hydrogen bond between O4 of the substrate and the amide backbone of a conserved 
serine or threonine. Substitution of the conserved residue with Pro resulted in a kcat/KM of  
1 M
-1
s
-1
; deletion of the FUMP O4 resulted in a product analogue that does not undergo H6 
exchange or inhibit decarboxylation. Hence, indirect evidence reveals the O4-backbone 
interaction plays an important role for binding and catalysis. 
OMPDC likely has honed multiple mechanisms to attain its remarkable catalysis. The 
successful crystallizations of OMPDC a decade ago sparked hypotheses that structure and 
sequence conserved residues induced productive strain on the substrate-enzyme complex. Here, 
we demonstrate a new source of stress: a hydrophobic pocket adjacent to the OMP carboxylate 
that exhibits kinetic parameters characteristic of substrate destabilization. Substitution of these 
residues with hydrophilic side-chains, by providing hydrogen-bonding partners, decreased kcat by 
10 to 10
4 –fold. The same substitutions display very little change in the rate of product H6 
exchange, supporting that this hydrophobic pocket affects the substrate-enzyme complex before 
the transition state. We also provide evidence that hydrophilic residues can insert water 
molecules into the pocket with detrimental effects to catalysis. 
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CHAPTER 1: INTRODUCTION 
 Orotidine 5’-monophosphate decarboxylase (OMPDC) catalyzes substrate 
decarboxylation with a rate acceleration of 10
17
, one of the largest catalytic enhancements ever 
measured for a cofactor-less enzyme (Fig.1).
1
 However, the source of acceleration is much 
debated; it is uncertain how OMPDC can speed decarboxylation without a cofactor or metal ion 
to stabilize an intermediate that most likely involves a localized carbanion. 
 
Figure 1: Reaction catalyzed by OMPDC. 
 
 OMPDC operates in the de novo pyrimidine nucleotide biosynthetic pathway by 
converting orotidine 5’-monophosphate (OMP) into uridine 5’-monophosphate (UMP) with 
downstream pathways leading to thymine and cytosine nucleotides. Most organisms also have a 
salvage pathway that recycles pyrimidine nucleosides, but some eukaryotic organisms such as 
Plasmodium falciparum, the causative agent of malaria, utilize only the de novo pathway. 
Attempts to exploit this disparity by selectively knocking down the de novo biosynthesis have 
encouraged the development of OMPDC inhibition studies for medicinal studies, but also for 
mechanistic work that could identify the enzymatic bases for catalysis. Inhibition studies have 
shed light on the properties of the active site and ligand binding: Most binding candidates alter 
functionalities of the pyrimidine head or replace it altogether, as contacts to the O2’ and O3’ 
ribose hydroxyl and the phosphate dianion moiety are critical to binding, but not directly to 
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catalysis. Deletions of the OMP ribose hydroxyl groups that form substrate-enzyme hydrogen 
bonds or mutations of their enzyme partners D20 or T79* (Methanothermobacter 
thermoautotrophicus numbering, where the asterisk indicates a residue from the second subunit) 
cause up to a 10
3
 reduction in kcat /KM.
2
 Removal of the phosphate dianion reduces catalysis by 
almost 10
5
-fold.
3
 
Many of the ligands examined for binding hint at the pathway and bases important for 
catalysis. The discovery of the extraordinarily tight affinity of OMPDC for 6-hydroxyUMP 
(BMP) is attributed to transition state-like binding, substantiating that the catalyzed pathway uses 
an anionic intermediate.
4
 Analogues that also contain electron density around C6, 6-azaUMP and 
6-aminoUMP, showed sub-micromolar inhibition values that further bolstered the claim that the 
reaction proceeds through a carbanion. Negatively charged, but bulkier, ligands such as 
sulfonoUMP, 5,6-dihydroOMP, and 6-phosphonoUMP (although lacking independent 
verification) have been reported to bind to the enzyme, suggesting that the active site 
accommodates large, negatively charged substituents at C6.
5-7
 These inhibition values led to 
claims that the enzyme structure stabilizes out-of-plane C6 groups. Analogues substituted at C5 
with halogen and cyano groups and dihydroOMP have led to speculation about a putative ―CO2 
binding pocket‖ in the active site. Inhibition studies in conjunction with sequence alignments 
highlight the conservation of active site architecture and residues that interact with the substrate. 
In spite of conserved active site residues and geometry, OMPDC sequences are highly 
divergent (less than 10% sequence identity within the family) and split into four major 
subfamilies identified by sequences and the length of the loop at the end of the 7
th
 β strand, 
which closes off the active site during catalysis.
8
 Although overall sequence identity can be very 
low, all OMPDCs fold into a dimer of (β/α)8 barrels with precisely placed and highly conserved 
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active site residues. Mechanistic hints can be found from the conserved protein sequence and 
structure. Each active site is located at the interface of the dimer and requires residues from both 
subunits for activity. These conserved residues include D70, K72 and D75* of the DxKxxD 
motif; D20 and K42 that form part of the ribose binding domain; and S127, Q185 and R203 that 
bind the pyrimidine and phosphate dianion. The conserved residues participate in the extensive 
hydrogen bonding and/or charged network lining the active site and assist in catalysis. 
Mutagenesis of any of these residues results in sizeable reductions in kcat/KM, if not near 
inactivation as in the case of K72.
2,9,10
  
The uncatalyzed reaction is calculated to have a rate of 10
-16 
s
-1
, which translates to a 
half-life of 78 million years.
1
 This sluggish rate results from the instability of the anionic 
intermediate because of the lack of resonance stabilization or an electron sink (Fig 2a). OMPDC, 
however, does not provide an obvious source of stabilization or reduction of the activation 
barrier. Consequently, how OMPDC can considerably increase turnover without a cofactor is of 
great interest and has generated a number of mechanistic proposals. 
 
Figure 2: (a) Putative anionic intermediate with negative charge localized at C6. (b) Structure of 
BMP inhibitor. Resonance between O4 and O6 of BMP mimic possible transition state 
delocalization.  
Silverman and Groziak proposed an addition-elimination reaction in which a nucleophile 
on the enzyme forms a covalent bond at C5 and protonates C6 (Fig. 3a).
11
 Concurrent loss of the 
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carboxylate as carbon dioxide and the nucleophile would yield product UMP without the 
formation of an anionic intermediate. However, no kinetic isotope effect was observed for 
isotopically labeled 5-
13
C or 5-
2
H OMP, eliminating nucleophilic attack at C5 as the mechanistic 
pathway.
12,13
  
Another proposal put forward a concerted protonation and decarboxylation that would 
bypass the generation of a high energy anionic intermediate (Fig. 3b).
14,15
 D2O solvent kinetic 
isotope effects and 
13
C labeled carboxylate kinetic isotope effects showed that decarboxylation, 
determined to be the rate-limiting step, was separate from protonation.
13,16
 In 50/50 D2O/H2O the 
measured product isotope effect is unity (i.e. equivalent amounts of protonated and deuterated 
product were observed spectroscopically), providing further evidence that protonation does not 
help initiate nor is concurrent with the rate determining step.
17
 Additionally, a 10
2
 -fold rate 
enhancement of decarboxylation and H6 exchange for 5-fluoroOMP and 5-fluoroUMP indicate 
an anionic intermediate that is stabilized by the inductively electron withdrawing fluorine 
(Fig. 2b).
12
 Overall, accumulated experimental evidence favors a two step reaction with a 
negatively charged intermediate over the concerted reaction. 
Several propositions utilized protonation as a means to stabilize the anionic charge of the 
intermediate since. Beak and Siegel suggested a zwitterionic or ylide mechanism where 
protonation of O2 yields a positively charged quaternary amine at N1 that could inductively 
stabilize the neighboring negative charge on C6 (Fig. 3c).
18
 A similar zwitterionic intermediate is 
found in thiamin pyrophosphate-catalyzed reactions. Lee and Houk proposed a similar 
delocalization scheme in which the anionic intermediate forms a carbene resonance structure 
with charge delocalized to O4 (Fig. 3d).
19
 Their proposal suggested that a conserved lysine, 
aided by a hydrophobic protein interior, transfers a proton to O4 to yield a neutral intermediate. 
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It was also noted that the transition state analogue 6-hydroxyUMP (BMP, Fig. 2b), a remarkably 
strong inhibitor with a Ki of 9x10
-12
 M
-1
 for yeast OMPDC, not only mimics the anion at C6, but 
can also generate an anion at O4 similar to the Lee and Houk intermediate (Fig. 2b). However, in 
2000 four crystal structures of OMPDC, from E. coli, M. thermoautotrophicum, S. cerevisiae, 
and P. falciparum, were published simultaneously.
14,20-22
 O2 and O4 form hydrogen bonds with 
the enzyme and play an important role in binding and in orientation of the substrate. However, 
the crystal structures showed that neither O2 nor O4 have nearby acidic proton donors, 
signifying that neither oxygen becomes fully protonated. 
15
N kinetic isotope effect studies 
performed with the 
15
N-labeled
 
picolinic acid show no bond order change, which contradicted 
the formation of a quaternary ammonium intermediate at or before decarboxylation, and was the 
final death knell for the zwitterionic mechanism.
23
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 Figure 3: Mechanistic schemes for OMPDC-catalyzed decarboxylation without 
generation of a unstabilized, high-energy intermediate. The main features of each proposal are 
highlighted in red. (a) Addition across the C5-C6 double bond followed by simultaneous 
decarboxylation and elimination of the nucleophile. (b) Concerted decarboxylation and 
protonation. (c) Ylide/zwitterionic intermediate facilitated by protonation at O2. (d) Carbene 
mechanism instigated by protonation at O4. (e) Ground state or substrate destabilization due to 
interactions between the OMP carboxylate and the nearby D70 charge.  
 
The 100+ currently deposited crystal structures of OMPDC reveal that the residues of the 
conserved DxKxxD motif point toward the C6 carboxylate group. The functional significance of 
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the two conserved aspartates is unclear, and this discovery prompted Wu et al. to suggest that 
OMPDC utilizes ground state destabilization.
21
 The concept of ground state destabilization 
originates from the Circe effect introduced by Jencks.
24
 Wu et al. proposed that the positively 
charged lysine ―entices‖ the substrate carboxylate into the proper active site conformation, but 
the neighboring negatively charged aspartates provide electrostatic stress that encourages 
decarboxylation (Fig. 3e). The strain is felt only by the Michaelis-Menton complex, thereby 
decreasing ΔΔG between the ground state and transition state. However, the hypothesis for 
ground state destabilization was countered by Florian et al., who responded that desolvation 
costs outweigh destabilization benefits.
25
 Although kcat would increase with heightened 
hydrophobicity, desolvation would increase KM and consequently kcat/KM would not improve. 
Ground state destabilization of the enzyme-substrate complex could utilize 
conformational changes to position the conserved aspartates effectively. The costs of desolvation 
or structural changes towards a catalytic conformation could be compensated by the intrinsic 
binding energy of the phosphate group. OMPDC decarboxylates the orotidine analogue 1-
(erythrofuranosyl)orotic acid (EO) very slowly—kcat/KM is 2.1 x 10
-2
 M
-1
s
-1
.
3
 In the presence of 
phosphite dianion, EO decarboxylation accelerates almost 10
5
-fold. Restoration of the 
phosphoryl moiety reconstitutes the original OMP kinetics, provided that the entropic effect of 
binding two substrate pieces is taken into account. Catalytic activation by the addition of 
phosphite supported the ―Jencksian‖ concept that enzymes redirect binding energy to ―pay‖ for 
catalysis.
24
  
In spite of extensive interrogation, the drive behind OMPDC catalysis is not completely 
clear and remains contentious. In reality the enzyme probably uses multiple elements to 
decarboxylate OMP, of which two possible mechanisms are described herein: carbene-like 
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resonance facilitated by hydrogen bonding—rather than proton transfer—and hydrophobic 
destabilization of the OMP carboxylate group. Mechanistic hypotheses explored in this thesis 
examine OMPDC from M. thermoautotrophicus as a model enzyme.
9 
 
CHAPTER 2: INVESTIGATION OF POSSIBLE TRANSITION STATE STABILIZATION BY 
CARBENE-LIKE RESONANCE STRUCTURES 
2.1 BACKGROUND 
 The discovery of the exceptional rate enhancement of OMPDC prompted a proliferation 
of proposals regarding the enzymatic stabilization of the carbanion intermediate. Houk and Lee 
suggested that the charge at C6 of the anionic intermediate delocalized onto O4 where it was 
stabilized by protonation.
19
 They calculated that the activation energy of the reaction was 
lowered by 28 kcal/mol if O4 were protonated, provided a proton donor was located nearby in a 
sufficiently hydrophobic environment to tune acceptor and donor pKas. Because sequence 
comparisons showed an absolutely conserved lysine, Houk and Lee suggested that the acid 
catalyst was this lysine (pKa~8), which would require assistance to protonate a carbonyl 
(pKa~0.5). Hence pKa tuning was invoked via a hydrophobic interior.
19,26
 With O4 protonation, 
C6 reorganizes into a neutral carbene with the lone pair residing in an sp
3
 orbital.  
However, subsequent crystallographic structures revealed the lack of a plausible proton 
donor near O4. Instead, O4 forms hydrogen bonds to the backbone amide of S127 and to a 
conserved water molecule. Although less advantageous than full protonation, OMPDC likely 
engages the O4-backbone amide bond to bind and help stabilize charge from C6. Computational 
analysis shows that charge is not on C6 alone, but spread throughout the pyrimidine ring.  
 Gene sequences and available crystal structures show that S127 and the amide-O4 bond 
are highly conserved in orthologous OMPDC enzymes as serine or threonine. 
 
 
 
10 
 
BACsu.7245429.1DBT R P S L I A V T Q L T S T S E Q I M K D E L L I 
 LISmo.224501367 R P K I I A V T Q L T S T S E T D M Q T E Q L I 
 GEOka.261375801 R P R C I A V T Q L T S T D E R M L H E E L W I 
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 AERpe.14602012 - - - L V L V V S M S H P G S R E V L D P C L D 
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                        Figure 4: Sequence alignment illustrating high conservation of S127 as serine or threonine 
among archeal, bacterial and eukaryotic OMPDC enzymes (ID includes genus and species name 
abbreviations, gi number, and pdb file). Crystal structures confirm that OMPDC orthologues 
utilize theonines and not the adjacent serines in amide-O4 bonds (pdb files 1DBT and 1L2U). 
 
Figure 5: S127 analogues and loop after the 7
th
 β strand, which caps the active site. The 
architecture and placement of key residues remain constant across the domains despite sequence 
divergence. Archeal M. thermoautotrophicus S127 and Q185 liganded with BMP (gray), 
bacterial B. subtilis T123 and Q194 with UMP (navy blue), eukaryotic S. cerevisiae S154 and 
Q215 with 6-azaUMP (cyan). 
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Because the hydrogen bonds formed between substrate and the S127 backbone and side chain are 
highly conserved and potentially enhance catalysis, the effects of hydrogen partner deletion by 
site-directed mutagenesis and substrate analogues were investigated.  
2.2 RESULTS AND DISCUSSION 
S127 Enzyme Mutagenesis. Mutational analysis of S127 underlines the magnitude of its catalytic 
or binding role. The importance of S127 lies in its dual hydrogen bonds: besides the bond 
between the OMP O4 and the S127 backbone amide, the hydroxyl side-chain of S127 bonds to 
N3 of the substrate and to another highly conserved residue, Q185, which in turn coordinates O2 
and R203, a key phosphate binding residue (Fig. 6a). S127 and Q185 together ―clamp‖ the 
substrate into the active site, however, deletion of the serine side-chain (5.7 kcal/mol) is 
effectively equivalent to the double deletion of both the serine and glutamate side chains (6 
kcal/mol). The magnitude of the S127 mutation demonstrates the major role of the S127 
hydrogen bonds in organizing the active conformation of the active site. The absence of enzyme 
contacts to O2, N3, and/or O4 of the pyrimidine ring of OMP probably hampers correct 
conformational binding, as illustrated by S127A co-crystallized with UMP: instead of the 
expected syn conformation, UMP binds in an anti conformation with O2 adjacent to the 
DxKxxD motif (i.e. the pyrimidine ring is flipped 180°).
27
 Yet, S127 mutants exhibit both 
increases in KM and decreases in kcat suggesting that the clamp is not limited to binding or 
substrate specificity, but also participates in transition state stabilization. 
12 
 
 
Figure 6: Active site clamp showing (a) hydrogen bonding network between BMP and clamping 
residues and (b) structural similarities and differences in the same residues between WT (gray), 
S127G (cyan) and S127P (magenta). Waters are color coded to match structure colors. 
 
The kcat for S127A is reduced by 100-fold, while KM is increased to 70 µM, yielding a 
second order rate constant kcat/KM of 5 x 10
2 
M
-1
s
-1 
(Table 1). This effect comes solely from the 
absent hydroxyl group and not from perturbation of the O4-amide backbone bond. S127G also 
displays impaired kinetic parameters, but appears to be partially rescued by a water molecule 
observed in the crystal structure (Fig. 6b). Because the water can fulfill some of the hydrogen 
bonding requirements, S127G consequently has a higher kcat/KM than S127A. However S127P, 
although it minimally alters the active site architecture, experiences an additional 800-fold 
reduction in kcat/KM compared to S127A. The effect of S127P compounds the deletion of S127 
hydrogen bonds to both O4 and N3, of which the extra 800-fold reduction in kcat/KM derives 
from the missing O4-amide bond. Although the amide backbone cannot be mutated as easily as 
side-chains are, the differential between the alanine and proline mutants show that the O4-amide 
interaction contributes at least ~ 4 kcal/mol to catalysis. S127P catalysis with an alternate 
substrate, FOMP, yields a kcat/Km of 1.4 x10
2
 M
-1
s
-1
. Based on impaired OMPDC mutants D70G 
13 
 
and D70N, the 5-fluoro substitution increases kcat/KM by 300 to 400-fold; S127P decarboxylates 
FOMP about 140-fold faster than OMP, which confirms the poor kinetic ability of S127P.
10
 
OMPDC kcat (s
-1
) KM (µM) kcat/KM (M
-1
s
-1
) 
WT 4.0 2.0 2.0 x 10
6 
S127A 0.049 62 7.9 x 10
2
 
S127G 0.28 92 3.0 x 10
3
 
S127P - - 1 
 
Table 1: Kinetic parameters for S127 mutants of Mt OMPDC. 
 
3-DeazaUMP Inhibition. I synthesized a product analogue, 3-deazaUMP, which lacks N3 of the 
uracil ring (Fig. 7). It acts as the complementary ―product mutant‖ to the S127A and S127G 
enzyme mutants, i.e. all of them exclusively eliminate the N3-S127 hydroxyl hydrogen bond. 
Therefore wildtype OMPDC with 3-deazaUMP and S127A mutant with OMP should exhibit 
comparable effects on ligand binding affinity. The mutant S127A, assuming KM approximates 
Kd, has a substrate binding affinity of 70 µM, which is almost 50-fold higher than wildtype. 
Based on S127A kinetics, deletion of the UMP N3 moiety ought to result in 50-fold weaker 
binding since the enzyme-substrate complex loses the same hydrogen bond. However, between 
pH 6 to 9, 3-deazaUMP has a Ki of 50 µM, which is about 4-fold lower than UMP Ki. 
 
Figure 7: OMPDC substrates (OMP, FOMP), products (UMP, FUMP) and analogues lacking 
key contacts involved in enzyme binding, N3 and O4 of the pyrimidine ring. 
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"Intact" Piece Interacting Partner  Ki (µM) Difference 
OMP 
+ WT OMPDC 1.5 Increase 
+ S127A OMPDC 70 50-fold 
WT OMPDC 
+ UMP 200 Decrease 
+ 3-deazaUMP 50 4-fold 
 
Table 2: Enzyme and product mutation that deletes a hydrogen bonding partner of the N3-S127 
interaction shows opposite trends. A consequence of N3 deletion causes 3-deazaUMP to have an 
elevated O4 pKa value, which may yield the disparity between apparent Ki trends. Provided that 
OMPDC could similarly modulate O4 pKa during the reaction, the enzyme could exploit the 
enhanced hydrogen bonding for intermediate stabilization.  
 
The incongruity between 3-deazaUMP binding affinity and S127A binding affinity might 
reflect the potency of the O4-backbone hydroxyl interaction (Table 2). The loss of affinity due to 
the absent N3-hydroxyl interaction might be compensated by a strengthened O4-backbone amide 
interaction that is facilitated by shifts in O4 pKa; 3-deazaUMP matches the pKa of the backbone 
amide better than UMP since the pKa of the 3-deazaUMP hydroxyl (ca. 6.5) is much larger than 
the orotate carbonyl pKa (ca. 0.5).
26,28
 Additionally, at the decarboxylation reaction pH 7.1, the 
majority of 3-deazaUMP inhibitor exists in an ionized state, thus the oxyanion charge, although 
partially delocalized onto O2, might further enhance hydrogen bonding. If the enzyme were 
capable of such O4 pKa tuning between ground and transition state, increasing hydrogen bond 
strength during the transition state would preferentially stabilize the high-energy intermediate 
and accelerate catalysis. Further investigation with the substrate analogue 3-deazaOMP or 3-
deazaBMP and 6-aza-3-deazaUMP inhibitors might clarify the interplay between weakened N3 
interactions and possibly strengthened O4 interactions.  
15 
 
Exchange of 4-Deoxy-5-FluoroUMP. 4-Deoxy-5-fluoroUMP (DFUMP, Fig. 7) was synthesized 
according to Driscoll et al.
29
 However, no exchange of H6 of DFUMP in enzyme concentrations 
up to12 mg/mL was observed by 
19
FNMR over a period of 15 days. One explanation is that 
OMPDC requires O4 for transition state stabilization and its absence demolishes exchange 
activity. Measuring exchange, however, is complicated by the apparent degradation of DFUMP 
at high concentrations of enzyme.
*
 Addition of 0.25 equivalents of DFUMP inhibited FUMP 
exchange only 3-fold, showing that DFUMP can only weakly compete with FUMP binding. 
Thus in addition to any catalytic incompetence, DFUMP poorly binds to the active site. 
2.3 CONCLUSIONS 
 Deletion of O4 from OMP, alteration of its hydrogen bonding strength, or mutation of the 
enzyme partner S127 shows that O4 is extremely important for binding and catalysis. Clearly O4 
plays a significant role in substrate and product binding as evinced by the lack of exchange 
inhibition by DFUMP or of DFUMP exchange itself. The product analogue 3-deazaUMP 
suggests the capacity of the O4-backbone amide interaction for strong hydrogen bonding, since it 
appears to partially rescue N3-hydroxyl deletion. Side-chain and backbone mutations to S127 
have both large kcat and KM effects. However, whether the O4-backbone interaction actually 
increases during catalysis to lower transition state free energy is still unclear. 
                                               
*
 DFUMP in high concentrations of enzyme was observed to degrade over 2 weeks as seen by 
decreasing intensity of DFUMP peaks in 
1
HNMR and 
19
FNMR spectroscopy). Slow glycosidic 
cleavage was also observed by Carlow et al. with DFUMP in the presence of cytosine deaminase 
and was attributed to minute enzyme impurities.
  
16 
 
CHAPTER 3: INVESTIGATION OF THE CONTRIBUTION OF THE HYDROPHOBIC CO2 
POCKET TO SUBSTRATE DESTABILIZATION 
3.1 BACKGROUND 
Hydrophobic interactions have long been recognized in guiding protein folding and 
enhancing substrate specificity. Enzyme active sites might also employ hydrophobic residues in 
catalysis to manipulate pKa values or the energetics of nearby charged groups. Strategically 
placed nonpolar sites have been previously conjectured for some enzyme chemistries such as 
thiamin pyrophosphate cofactor-dependent reactions. Non-enzymatic decarboxylation of 
pyruvate to acetylaldehyde occurs10
4
-10
5
 times faster in ethanol than in water when in the 
presence of thiamin derivatives.
30
 Other works showed that pyruvate dehydrogenase binds the 
neutral transition state analogues thiamin thiazolone pyrophosphate and thiamin thiothiazolone 
pyrophosphate over positively charged forms by a factor of at least 20,000.
31
 The solvent effects 
and inhibition by transition state analogues implicate active site hydrophobicity in these 
thiamine-dependent enzyme reactions. Enzymes such as pyruvate dehydrogenase and pyruvate 
decarboxylase may bind thiazolium groups in a hydrophobic region to disfavor charged species 
and drive the reaction toward a favorable neutral intermediates.  
OMP decarboxylation, which removes a negative charge in generating the UMP product, 
is another candidate for hydrophobicity-assisted catalysis. Experimental and computational work 
have shown that decreasing solvent polarity or the dielectric constant of the reaction increases 
the rates of OMP decarboxylation.
19,32
 The results support hydrophobic environments that favor 
neutral structures over charged molecules, e.g,. greasy interiors that prefer UMP to OMP or K72 
as an amine rather than an ammonium cation. Non-enzymatic decarboxylation of orotate 
derivatives in organic solvents have shown 10 to 10
3
-fold enhancements versus the aqueous 
17 
 
reaction, presumably by increasing the free energy of the reactants and consequently decreasing 
the activation barrier.
32
 However, for kcat to increase, this interpretation assumes the anionic 
intermediate free energy is not equally elevated by the solvent hydrophobicity; possibly 
delocalization of the intermediate charge throughout the ring helps stabilize the intermediate. 
The reaction rate increase in organic solvents shows a strong negative correlation to the solvent 
acity (anion solvating tendency), illustrating that aprotic environments improve decarboxylation 
versus protic or solvating environments. Similarly, the enthalpy of orotate decarboxylation 
modeled with an ammonium cation proton source was dramatically dependent on dielectric 
constant, ε: in water (ε = 78), both the experimental and calculated enthalpy of reaction is 42 
kcal/mol, but the enthalpy in a hydrophobic enzyme interior (estimated ε = 4) is a calculated 23.9 
kcal/mol lower.
19
  
As has been pointed out in computational analyses, catalysis based on the desolvation of 
the substrate would be associated with a large free energy cost (est. 32 kcal/mol) that may exceed 
the binding energy provided by the phosphate group (approximately 11-12 kcal/mol).
25,32
 The  
unfavorable energetics of eliminating hydrogen bonds could override the benefits of catalysis 
driven by hydrophobic effects. Additionally, the substrate is enveloped by an extensive hydrogen 
bonding network that suggests that the active site is largely polar rather than nonpolar. However, 
a hydrophobic region within the active site might reap the catalytic benefits of hydrophobicity 
without paying the full price of desolvation. 
 A related mechanism, electrostatic repulsion, which also destabilizes the substrate, has 
been investigated. Typically, OMPDC kinetics are measured via decarboxylation; however, 
enzyme activity can be examined in terms of exchange of H6 on the pyrimidine ring (Fig. 8a). 
The enzyme active site decreases the pKa of UMP by at least ten pKa units, enabling 
18 
 
exchange.
10,33
 Both decarboxylation and exchange engender the anionic intermediate, and, 
therefore, both are expected to utilize the same transition state stabilization mechanisms; any 
enzyme functionality that contributes to transition state stabilization should have equal effects on 
decarboxylation and exchange rates. However, only substrates with C6 carboxylates experience 
pre-transition state interactions, thus only decarboxylation could undergo destabilization (Fig. 
8b). Consequently, changes in kcat minus changes in kex reflect effects due to diminished 
destabilization.   
 
Figure 8: Decarboxylation (red) and H6 proton exchange (blue) reactions for OMPDC. Both 
reactions proceed through the anionic intermediate (‡), but only decarboxylation is subject to 
pre-transition state (pre-TS) strain. 
 
Work performed by Chan et al. showed that mutagenesis of the first aspartate (D70) of 
the DxKxxD triad to asparagine or glycine exhibited decarboxylation rates reduced by 100 to 
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1000-fold, but had no effect on the rate of FUMP exchange.
10
 This suggests a catalytic 
mechanism important to decarboxylation but not accessed in the transition state. D70 might 
selectively contribute electrostatic and steric stresses that increase the free energy of the enzyme-
bound substrate, but not the intermediate. In conjunction with electrostatic repulsion, a 
hydrophobic environment could also contribute to catalysis via destabilization of the enzyme-
substrate complex. The effects of hydrophobicity, which are presented in this thesis, can be 
similarly investigated by a comparison of OMPDC catalyzed reactions. 
 Structural data capture possible ―stressed‖ ligands bound in the active site.  Catalytically 
inactive Mt OMPDC K72A and D70A/K72A mutants crystallized with OMP (1km6) and 6-
cyanoUMP (2zz2) show the C6 substituents twisted out of the aromatic plane. The active site is 
apparently able to distort substrate or substrate analogues even with the D70A mutation, possibly 
by utilizing the water molecules that fill the cavity produced by alanine substitutions. These 
structures may point to an enzyme active site that is designed or predisposed through steric 
and/or electronic effects to favor distortion of C6 substituents. For instance, a hydrogen bond to 
K42 might stabilize the twisted carboxylate OMP in 1km6. The surrounding network of other 
hydrogen bonding residues might orient waters or DxKxxD side-chains to force large C6 
substituents out of plane. Serendipitously, activated waters were also shown by crystallization of 
OMPDC with cyanoUMP: the structure captured the transformation of cyanoUMP to BMP 
(2zz1), perhaps another indication of an active site able to destabilize C6 functional groups. 
 Solvent effects, computation, mutagenesis, kinetics and structural work allude to 
destabilization mechanisms in OMPDC decarboxylation. However, the enzyme could maintain 
multiple means to accomplish this effect. Electrostatic repulsion primarily by a single residue, 
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D70, has been demonstrated. Parallel efforts showing hydrophobic destabilization via a greasy 
―CO2 pocket‖ are described in the following sections. 
3.2 RESULTS AND DISCUSSION 
Structural and kinetic analyses have uncovered an active site hydrophobic pocket 
comprised of at least six residues that are adjacent to the C6 carboxylate group of OMP, and 
which may work in tandem with the highly conserved DxKxxD motif to destabilize the C6 
carboxylate. The C6 carboxylate is cradled by the charged triad on one side and hydrophobic 
pocket residues on the other. Previous crystallographic data and inhibition studies suggest that 
the polarity and architecture of this region appear to bind ―bent‖ or bulky anionic structures 
including OMP, cyanoUMP, aminoUMP, dihydroOMP, sulfonoUMP, phosphonoUMP and 
pyrazofuran monophosphate (although independent analyses have yet to confirm some of these 
inhibition values).
6,7,21,27,34
 Through electrostatic and/or steric effects, the DxKxxD motif might 
push OMP’s carboxylate group into the hydrophobic pocket to accelerate decarboxylation. On 
the other hand, the pocket residues and the DxKxxD motif might be complementary, but 
structurally and mechanistically independent, means of destabilization that assist in 
decarboxylation. 
These pocket residues reside on the ends of five β strands of the barrel. Hydrophobic 
pocket residues consist of I96 (4
th
 β strand), L123 (5th β strand), V155 (6th β strand), I178 and 
P180 (7
th
 β strand), I200 (8th β strand). The aliphatic chains of K42 and K72 might also 
contribute to pocket geometry and hydrophobicity. The pocket was investigated with a two-
pronged approach to uncover the contribution of the hydrophobic pocket to catalysis. In the first 
method, I replaced hydrophobic residues with polar serines, threonines or asparagines (Fig. 9). 
21 
 
Increased polarity could stabilize the charge on OMP and disfavor catalysis by lowering the free 
energy of substrate-bound enzyme complexes before the intermediate. 
 
Figure 9: Two approaches to identify and/or quantify the contribution of the CO2 hydrophobic 
pocket. The first consists of hydrophobic residue replacement with hydrophilic residues. The 
second substitutes large residues into pocket cavity to create a hydrophobic wall.  
 
Residues with polar side-chains produced mutant OMPDCs with kcat values attenuated by 
10 to 100-fold, but with virtually no effect for KM (Table 3). Decarboxylation rates decreases 
proportionally to polarity.  From most detrimental to catalysis to least, aspartate > serine > 
threonine ~ asparagines. The reductions in kcat substantiate the hypothesis that the pocket 
residues play some role in catalysis, but do not alter binding affinity or enzyme conformational 
changes to the closed, active structure. Exchange rates of the H6 proton of FUMP, kex, were 
typically within a factor of three from wildtype values. FUMP instead of UMP was used to 
exploit the close, but well differentiated, 
19
F-NMR peaks of protonated and deuteriated FUMP 
and to circumvent the loss of enzyme activity that occurs with protracted UMP exchange. 
Altogether the kinetic data, similar to the D70 mutagenesis conclusions, indicate that these 
pocket residues are not involved in binding or transition state stabilization, but do assist 
decarboxylation by adding strain to the C6 carboxylate. Even more startling, a substitution with 
an anionic residue, V155D, showed a dramatic 8000-fold decrease in kcat, but no effect on KM. In 
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the context of the total OMPDC acceleration, which increases the rate by 10
17
-fold and provides 
ca. 25 kcal/mol stabilization to the uncatalyzed reaction, exchanging a greasy valine for charged 
aspartate demolishes nearly 20% of OMPDC catalysis! Contrary to the other mutations, V155D 
actually appears to slightly increase kex rates. Surrounded by hydrophobic residues, the pKa of 
V155D might be raised and the aspartic acid could provide a protonation source that contributes 
to the rate of exchange. 
OMPDC kcat (s
-1
) KM (µM) kcat/KM (M
-1
s
-1
) kex (s
-1
) 
WT 4.0 1.6 2.0 x 10
6
 0.015 ± 0.004 
I96T 0.69 ±0.05 2.3 ± 0.06 3.0 x 10
5
 0.0047 ± 0.0004 
I96S 0.011 ± 0.002 1.0 ± 0.04 1.0 x 10
4
 0.006 ± 0.001 
L123N 0.64 ± 0.01 3.5 ± 0.2 1.9 x 10
5
 0.0007 ± 0.0001 
L123S 0.36 ± 0.04 3.0 ± 0.5 1.2 x 10
5 
0.00039 ± 0.00001 
V155S 0.011 ± 0.003 4.7 ± 0.4 2.2 x 10
4
 0.006 ± 0.003 
V155D 0.0005 ± 0.0002 4.6 ± 0.5 4.6 x 10
2
 0.057 ± 0.002 
 
Table 3. Kinetic parameters for polar substitutions into hydrophobic pocket. All mutants 
diminished decarboxylation without altering KM significantly, but highlighted are mutants that 
decrease decarboxylation without large changes in the rate of H6 exchange. 
 
In crystal structures with the inhibitor BMP, the mutant polar pocket enzymes display 
active sites that are extremely similar to wildtype OMPDC despite the large differences in kcat. 
The bound ligand and essential residues outside the pocket are completely superimposable on 
wildtype and pocket-forming residues are virtually undisturbed except for the mutations 
themselves (Fig. 10). Two conserved water molecules near O4 and C6 appear to be the most 
mobile elements, and L123S coordinates a third water inside the cavity. The BMP structures 
validate the hypothesis that the diminished kcat values are attributable to the loss of 
hydrophobicity, since the introduced polar residues modify the electronic environment without 
23 
 
disrupting architectural features. The polar pocket residues do not collapse the pocket, but satisfy 
part of their hydrogen bonding imperative by bond formation to the OMP carboxylates that 
coordinate the carboxylate but ultimately block decarboxylation. 
 
 
Figure 10: Overlay of BMP co-crystallized wildtype OMPDC (goldenrod) and pocket 
mutantsI96S (salmon), I96T (navy blue), L123S (forest green), L123N (firebrick), V155S 
(cornflower blue), and V155D (lime green). Shown are active site residues involved in binding 
ligands, the hydrophobic pocket and the DxKxxD motif. (a) Typical view oriented down the 
down the α/β barrel. (b) View along the plane of the BMP pyrimidine ring. The pocket is on the 
ligand’s left and DxKxxD motif on the right. 
 
Alternatively, the movement and/or the addition of water molecules in the pocket region 
of BMP co-crystal structures may indicate that the polarized pockets stabilize a water molecule 
within the pocket cavity that inhibits decarboxylation with hydrogen bonds or unfavorable steric 
interactions with the departing C6 carboxylate. Mutants, such as L123S and L123N, which show 
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kinetic perturbations, but are too far from the C6 site for efficient interaction with the 
carboxylate, may recruit waters to the pocket. 
  
   
Figure 11: Pocket mutants co-crystallized with BMP superimposed over wildtype (goldenrod). 
Only pocket waters show significant displacement within the active site. (a)Mutant V155S 
(cornflower blue) and V155D (lime green) with wildtype.(b) Mutant L123S (forest green) and 
L123N (firebrick) with wildtype. 
 
 The polar side-chains of the V155 and L123 mutations are within hydrogen bonding 
distance (< 3 Å) of the C6 water, which might mimic the position of the carboxylate oxygens 
(Fig. 11). Thus V155D, V155S, L123S and L123N might stabilize the ground state through new 
bonds between the carboxylate, enzyme and possibly waters. These interactions lessen the 
hypothesized strain conducive to decarboxylation. However, hydroxyls of I96S and I96T are not 
optimally positioned toward C6 (the distance between side-chain hydroxyl and O6 is 6Å 
(Fig. 12), but instead are oriented away from the pocket cavity. Based upon the BMP structures, 
I96 mutant hydroxyls may prefer to form hydrogen bonds to D70. These mutants are not forming 
additional stabilizing carboxylate contacts as other pocket mutants are, but perhaps are acting as 
hydrogen bond donors to D70. Ultimately I96S and I96T have the same effect as other polar 
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pocket mutants, but might impair the destabilization imparted by the D70 negative charge rather 
than stabilizing the substrate directly.  
 
 
Figure 12: A structural comparison of wildtype (goldenrod) and I96S (salmon) and I96T (navy 
blue) mutants co-crystallized with BMP. I96 mutants may neutralize ground state destabilization 
by either stabilizing the OMP carboxylate or the nearby D70 carboxylate. (a) Typical view 
oriented down the α/β barrel. (b) Top view of the active site and pocket, highlighting the relative 
proximity between I96 mutant side chains and D70, in contrast to I96 and ligand C6. 
 
 To investigate potential cooperativity between electrostatic repulsion and I96S or I96T, 
the kinetics of the double mutant D70N I96S and D50N V155S were measured. Pocket mutants 
that impair catalysis by thwarting D70 destabilization would have kinetic parameters similar to 
the D70 mutation alone. A feature that affects only the aspartate should have no effect when the 
aspartate is replaced. However, both double mutations expressed fully multiplicative kcat effects, 
indicative of independent mechanisms (Table 4).  
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 The absence of interaction between pocket mutants and the DxKxxD motif corroborates 
H6 exchange observations. If I96 mutants formed hydrogen bonds with D70, H6 exchange 
kinetics might be expected to increase as the exchange rate is limited by the rotation rate of K72, 
which is slowed by its electrostatic attraction to D70. Introducing interactions between a serine 
or threonine and D70 would diminish the interaction strength between D70 and K72 and 
consequently enhance rotation and exchange rates. However, the exchange rates of the I96 
mutants are identical to the V155S rate. 
 In spite of five orders of magnitude decrease in their decarboxylation rate, the double 
mutants D70N I96S and D70N V155S experience less than a ten-fold decrease in exchange rates, 
providing evidence that though separate, the hydrophobic pocket and electrostatic repulsion 
induce productive strain on the same pre-transition states during decarboxylation. 
 Single mutations Double mutations 
kcat (s
-1
)  kexchange (s
-1
) projected kcat (s
-1
) kcat (s
-1
) kexchange (s
-1
) 
WT  4.0 0.015  --  --  --  
D70N  0.024 (200)  0.005 (3)  --  --  --  
I96S  0.011  (400)  0.006  (3)  0.0003  0.00006 (5)  0.002 (8)  
V155S  0.011 (400)  0.006 (3)  0.0003  0.00018 (1.5)  0.002 (8)  
L123S  0.36 (10)  0.0004 (40)  0.009  0.00093 (10)  0.00001 (1100)  
 
Table 4: A comparison of single mutations of pocket and D70N mutations to double mutations. 
In parenthesis are the decreases in rate compared to wildtype. In bold parenthesis are the 
decreases in rate compared to the projected rates for fully multiplicative effects. D70N I96S and 
D70N V155S are essentially multiplicative in nature. 
 
 A subset of these hydrophobic pocket mutants consistently presented diminished 
exchange rates as well as decarboxylation rate decreases. Unlike the most of the pocket mutants, 
this group weakens or hinders effective transition state stabilization. To reveal any binding 
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differences caused by a hydrophilic pocket, I tested the inhibition of azauridine 5’-
monophosphate (azaUMP) of the pocket mutants and D70N. Compared to wildtype or other 
pocket mutants, the anomalous L123 mutants also display tighter binding of azaUMP (Fig. 13). 
 
Figure 13: AzaUMP inhibition of wildtype and mutants. The mutants form two trends: L123S  
(navy blue) and L123N (pink), which exhibit heightened azaUMP inhibition, while the other 
mutants shown decreased inhibition compared to wildtype OMPDC (orange). 
 
OMPDC KM (µM) Ki (µM) (Ki)WT/(Ki)mut KM/Ki (KM/Ki)mut/(KM/Ki)WT 
WT 1.4 ± 0.3 0.6 1.0 2.7 1 
I96T 1.1 ± 0.4 0.76 0.8 1.4 0.5 
I96S 1.7 ± 0.3 5.7 0.1 0.3 0.1 
V155S 4.7 ± 0.4 5.2 0.1 0.8 0.3 
L123S 3.0 ± 0.6 0.043 14 69 30 
L123N 4.4 ± 0.3 0.085 7 53 22 
D70N 5.5 ± 0.2 18 0.03 0.3 0.1 
 
Table 5: Comparison of mutant KM and azaUMP Ki values. (Ki)WT/(Ki)mut shows the differences 
in Ki, KM/Ki corrects the inhibition factor by accounting for binding differences between 
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mutants, (KM/Ki)mut/(KM/Ki)WT shows the relative inhibition effects with different KM accounted 
for. 
 The Ki of L123 mutants are approximately 10-fold greater than wildtype; however, if KM 
values are taken account—slightly elevated compared to wildtype—the relative inhibition 
increases to 25-fold (Table 5). Subsequent crystal structures produced by the Almo laboratory at 
the Albert Einstein College of Medicine showed that pocket mutants, like earlier crystal 
structures of D70 and D75 mutants, bind azaUMP in the anti-conformation (Fig. 14). AzaUMP 
typically binds to wildtype and most active site mutants in the syn-conformation to take 
advantage of the ―active site clamp‖ to achieve favorable enzyme contacts to O2, N3 and O4 of 
azaUMP. Consequently, the proper reference for pocket mutant inhibition constants is not 
wildtype OMPDC, but D70 or D75 mutations. Compared to D70N, L123 mutants have 200-fold 
improved inhibition.  
 The origin of L123 mutants’ tighter binding of azaUMP, and presumably their anomalous 
exchange rate, might lie in the water maps shown by crystallography. D70 and D75 mutants lack 
an ―active site clamp‖ that helps hold the pyrimidine ring in position; however, converting the 
pocket to a more hydrophilic cavity permits ordered waters to solvate azaUMP O2, N3 and O4; 
the pocket mutants generate a pseudo-active site clamp. The consequence of the water clamp is 
two-fold: the waters in V155S, I96S and I96T upset L123 geometry. In light of M. 
thermoautotrophicum OMPDCs near imperturbable active site, these small changes might 
indicate substantial enzyme ―discomfort‖.  In contrast, L123 mutants waters are perfectly aligned 
to facilitate simultaneous bonds to enzyme and ligand.  
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Figure 14: OMPDC pocket mutants co-crystallized with azaUMP. In light gray are hydrogen-
bonding networks within the pocket and D70 and K72. (a) wildtype OMPDC [pdb file 3g1a], (b) 
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D70N [pdb file 3g24], (c)V155S, (d) I96S, (e) L123S, (f) I96T, (g) L123N. Gray lines indicate 
hydrogen bonding networks predicted by Chimera. 
 Pocket mutants L123S, I96S, and V155S hold two extra ordered waters, whereas I96T 
and L123N have only one. The number of ―clamp‖ waters in the azaUMP structures has no 
correlation to the azaUMP inhibition constants; L123N and L123S which exhibited the 
unexpectedly low Ki values have one and two waters respectively. Rather, binding strength 
probably reflects pocket residue geometry and the efficacy of the hydrogen bonding networks 
involved in water and ligand binding. 
Decreasing decarboxylation rates with static exchange rates for I96 and V155 mutants 
provide evidence that hydrogen bond partners stabilize pre-transition states of OMP 
decarboxylation. The slow exchange, elevated azaUMP inhibition, and azaUMP and BMP waters 
maps for L123 mutants indicate that these mutants worked differently. Based upon the favorable 
water contacts found in the crystal structures, L123 mutants may be able to incorporate a pocket 
water molecule into the active site. 
 L123 mutants bind azaUMP 200-fold more tightly, but their KM values are altered by 
only two or three -fold. The decarboxylation rate, kcat, is only mildly affected (around 8-fold) 
although exchange drops by a factor of 21 to 39.  A possible explanation for these incongruities 
is that mutants containing these extra waters do not productively bind OMP, i.e. decarboxylation 
cannot occur because of the steric and electronic effects of a water crowding the cavity. Since 
such a water-bound enzyme may be inactive for decarboxylation, the effective concentration of 
OMPDC is lowered, which consequently increases KM.  L123 mutants show a KM multiplied by a 
factor of 2-3. L123 mutants without the rogue water function almost as wildtype, experiencing 
only a ca. 8-fold decrease in kcat, which could be attributed to active site substitution effects. The 
31 
 
conversion of L123 to serine could have a smaller kcat effect than the analogous V155 or I96 
substitutions because the L123S side chain is comparatively deeper within the pocket, precluding 
effective hydrogen bonds the OMP carboxylate.  
Because FUMP has no C6 substituent, exchange may continue in the presence of extra 
waters, albeit at a decreased rate due to altered electronic and steric conditions near the pocket 
and DxKxxD motif. Similarly, azaUMP has no C6 substituents, which allows the ligand to 
exploit the pocket waters and flip to a more favorable ring conformation that leads to tight 
binding for L123 mutants.  
 
 The hydrophobic pocket was also explored with a second, more subtle mutagenesis 
approach, which added bulkier hydrophobic residues into the cavity to retard effective 
destabilization (Fig. 9). Adding steric hindrance could close off the so-called ―CO2 binding site‖ 
and prevent the substrate carboxylate from being moved out of the aromatic plane or pushed into 
the greasy pocket. Simultaneously it would preserve the effects of hydrophobicity. Bulk was 
added by single or double replacements of small pocket residues with leucines or isoleucines. 
These mutants have yielded wildtype-like kinetic parameters (10-fold or less differences, Table 
6). The incorporation of phenylalanines, in contrast, exhibited drastically altered kinetics for 
decarboxylation, binding and exchange.  
OMPDC kcat (s
-1
) KM (µM) kcat/KM (M
-1
s
-1
) kex (s
-1
) 
WT 4.0 2.0 2.0 x 10
6
 0.015 ± 0.004 
V155I 1.7 ± 0.1 1.0 ± 0.2 1.7 x 10
6
 0.010 
I96L 0.24 ± 0.06 0.52 ± 0.03  4.6 x 10
5
 0.011 ± 0.002 
I96L/V155I 1.9 ± 0.03 1.1 ± 0.08 1.7 x 10
6
 0.012 
V155F 0.0082 ± 0.0002 58 1.4 x 10
2
 0.000011 
I200F 0.063 ± 0.002 110 5.7 x 10
2
 0.0000075 
 
Table 6: Filling the pocket by replacement of pocket residues with bulkier hydrophobic residues. 
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Published crystal structures and inhibition constants suggest that the pocket is able to 
accommodate variously sized C6 functionalities: carboxylates, phosphonates, sulfonates, cyanide 
and extra water molecules. Perhaps predictably, mutations to leucine and isoleucine apparently 
are not large enough to perturb the pocket cavity. Phenylalanines, in contrast, appear to be too 
large or inappropriately oriented and actually impede both substrate binding and catalysis, 
possibly by forcing the nucleotide into less productive conformations. As H6 exchange is 
significantly reduced, phenylalanines affect more than pre-transition states of decarboxylation.
3.3 CONCLUSIONS 
A pocket adjacent to the active site composed of hydrophobic side chains was predicted 
to partially destabilize the substrate within the active site to promote OMPDC catalysis. Polar 
substitutions of pocket residues estimate the contribution of hydrophobicity to destabilization 
and catalysis, while the second approach described, bulk substitution, reflects the degree that the 
enzyme employs the cavity space itself—e.g. a space to ―push‖ the carboxylate into and/or out of 
the aromatic plane. Polar residues unambiguously decrease the reaction rate, so the enzyme 
clearly exploits hydrophobicity to assist decarboxylation. The necessary size of the pocket is less 
straightforward because of the lack of intermediate sized and shaped residues to sufficiently 
probe the pocket. 
The hydrophobic cavity demonstrated an effect upon the decarboxylation capacity of 
OMPDC, but little alteration for exchange, which is characteristic of pre-transition state strain. 
Simultaneously, mutation of this pocket does not alter the enzyme’s affinity for the substrate. 
Crystal structures exhibit active sites residues bound to the transition state analogue BMP that 
are virtually superimposable with wildtype, supplying further evidence that transition state 
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stabilization effects or structures are unaltered. These results suggest that the pocket residues 
decrease the activation barrier by exclusive destabilization of the pre-transition state enzyme-
substrate complexes.  
Kinetic analyses of D70, an essential OMPDC residue, and hydrophobic pocket mutants 
demonstrate that both of these architectures generate similar destabilization of the substrate-
bound enzyme. The charged OMP carboxylate is strained by hydrophobic residues on one side 
and electrostatic repulsion on the other. Cumulative effects on decarboxylation show that these 
means of destabilization work as distinct mechanisms. Consequently, in spite of suggestive 
crystallographic evidence, D70 does not push the charged carboxylate into the pocket. Although 
this result does not disallow carboxylate bending, as proposed by reports that the enzyme 
stabilizes distorted C6 substituents, the impetus for the substrate to overcome both aromatic 
resonance and hydrophobic repulsion in order to bend is unclear. 
Computational modeling in low dielectric environments and non-enzymatic 
decarboxylation in organic mediums have long shown that the sluggish rate of uncatalyzed OMP 
decarboxylation originates from the strong solvating power of water. Hydrogen bonds to the 
carboxylate so stabilize OMP that ΔΔG between reactant and intermediate is staggeringly large 
compared to most non-cofactor assisted enzymes. Although not the only basis for an acceleration 
of seventeen orders of magnitude, OMPDC responds to the thermodynamic disadvantage of 
aqueous or aqueous-like environments. The enzyme active site evolves many favorable contacts 
to substrate, but also engineers a hydrophobic pocket immediately next to the carboxylate, which 
I have demonstrated to be valuable for catalysis in this thesis.
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CHAPTER 4: MATERIALS AND METHODS 
OMPDC Site-Directed Mutagenesis, Expression and Purification. OMPDC from 
Methanothermobacter thermoautotrophicus was cloned into a pET15b vector to use as a 
template for site-directed mutagenesis. Mutations were incorporated into OMPDC by the overlap 
extension procedure. Primers containing the desired mutant codons were synthesized by Eurofins 
MWG Operon. In the initial step, PCR reactions with the mutant primers generate OMPDC 
sequence in two halves: GerltT7pro and the mutant-containing reverse primers yield the 
beginning of the sequence to the mutation site, while GerltT7term and the mutant-containing 
forward primers yield the sequence from the mutation site to the end of the sequences. The 
sequences were amplified under the following PCR conditions: 1X Taq buffer (Invitrogen), 
4 mM MgCl2, 0.8 mM dNTPs, 30 pmol template, 0.4 µM of each primer and 2.5 U native Pfu 
polymerase (Stratagene) and brought to a final volume of 50 µL with Millipore-ultrafiltered 
water. PCR program: 4 min at 95°C, followed by 25 cycles of 45 seconds at 95°C, 30 seconds at 
54°C, 135 seconds at 72°C, then 72°C for 7 minutes. The products were checked and purified by 
1% agarose gels stained with ethidium bromide. The two half genes, which overlap at the 
mutation site, were used as templates for PCR to generate the full length gene. The PCR 
conditions for the full length gene used1X Taq buffer, 4 mM MgCl2, 0.8 mM dNTPs, 5 µL of 
each half genes, and 2.5 U native Pfu polymerase. 
The PCR product and pET15b template were separately digested by Nde I (Promega) for 
approximately 16 hours at 37°C and Bam HI (Promega) for 3.5 hours at 37°C. The double-
digested pET15b template was treated with calf intestinal alkaline phosphatase (Stratagene) for 
two hours at 37°C to prevent religation of the vector to itself. Insertion of the gene into the 
pET15b vector was achieved using buffered T4 DNA ligase (Promega) for 16 hours at 16°C. 
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1 uL of ligation product was electroporated (1.8 mV) into electrocompetent E. coli XL1blue 
cells. All electrocompetent cells were prepared by inoculating 2 L Luria-Bertoni broth with an 
overnight six-mL starter culture, growing to log phase (OD600 = 0.6), and harvesting the cells. 
Media was removed from the cells with 1 L and 500 mL ice water washes, 40 mL cold 10% 
glycerol, and stored at -80°C in 10% glycerol. Electrocompetent cells were checked for 
ampicillin, kanamycin and chloramphenicol resistance.  
 DNA was isolated from a six-mL culture of XL1blue cells containing the vector and 
prepared using the QIAprep Miniprep Kit (Qiagen). DNA sequencing was performed by the 
University of Illinois Core Sequencing Facility to confirm the mutagenesis product sequence. 
Verified sequences were electroporated into pyr
-
 (OMPDC negative) E. coli competent cells 
containing the auxiliary plasmid pTara, which encodes for chlorampheicol resistance and T7 
polymerase. 
A single colony was selected to inoculate six mL starter cultures containing 100 µg/mL 
ampicillian, 50 µg/mL kanamycin and 34 µg/mL chloramphenicol. When the cultures became 
confluent, they were used to inoculate twelve liters of media with the same antibiotic 
concentrations, which were grown at 37°C and 220 rpm for 14-18 hours. Cells were harvested by 
centrifuging at 5000 x g at 4°C for 10 minutes. Cells were resuspended in binding buffer 
(Appendix 5.4) and lysed by pulse sonification for 12 minutes. Cellular debris was pelleted by 
31,000 x g centrifugation for 50 minutes and the supernatant was injected onto a 100 mL Ni
2+
 
column. His-tagged protein was eluted on an 0- 1.0 M imidazole gradient, collected, and 
dialyzed twice in 20 mM tris buffer (pH7.9) for a minimum of 3 hours each at 4°C. 
The His-tag was removed by a 20-hour incubation with ½-1 U thrombin per milligram of 
protein at room temperature in phosphate buffer. Complete cleavage was checked by SDS-
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PAGE. Protein purification was completed with a Q-sepharose column, a strong anion exchange 
resin, and the protein was eluted with a 0-1.0 M NaCl gradient. Fractions containing protein, 
typically eluted at 0.4 M NaCl, were collected and dialyzed twice in 20 mM HEPES buffer 
(pH7.5), 150 mM NaCl, and 3 mM DTT for a minimum of 3 hours each at 4°C. Amicon with 
10,000 MW filters were used to concentrate protein to 12-40 mg/mL, which were subsequently 
frozen in liquid nitrogen and stored at -80°C. 
 
1-Ribofuranosylbarbiturate monophosphate (BMP) Synthesis. BMP was synthesized according 
to a modified procedure by Levine, Brody and Westheimer.
4
 6 mmol Barbiturate was added to 
12 mmol trimethylchlorosilane and 72 mmol hexamethyldisilizane and refluxed for 30 minutes 
to 2 hours until solution was clear. Excess hexamethyldisilazane was removed by high vacuum 
rotary evaporation followed by 1 hour under vacuum at 60°C.  
The dried crystals were dissolved in dichloroethane and added to 5.5 mmol 1-acetyl-
2,3,5-tribenzoylribofuranose and 6 mmol SnCl4. The flask was purged with nitrogen gas and 
stirred overnight (typically 14 hours at room temperature). The condensation reaction was 
worked up with saturated sodium bicarbonate and saturated sodium chloride. The organic layer 
was further purified by filtering through Celite layered over a sintered glass frit filter. TLC (2-
propanol/concentrated NH4OH/H2O, 7:1:2) easily distinguishes between nucleoside (Rf = 0.7) 
barbiturate/silylated barbiturate (0.5), and 1-acetyl-2,3,5-tribenzoylribofuranose (0.9). 
Dichloroethane was removed by rotary evaporation and the protected nucleoside was 
redissolved in methanol. Benzoate protecting groups were either removed by ammonia gas 
(40 psi) in a Parr shaker for 48-72 hours or by 0.08M methoxide in methanol for 12 hours at 
room temperature. After deprotection, methanol was evaporated and the nucleoside was purified 
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by an aqueous work up with ethyl acetate and then loaded onto a 100 mL Dowex AG 50x8 resin 
(H
+ 
form). Barbiturate ribofuranose was eluted quickly from the column with water the 
nucleoside-containing fractions were collected, rotary evaporated and lyophilized. 
Recrystallization in water to remove remaining tribenzoylribofuranose and free ribose.  
Phosphorylation was achieved by a modified procedure by Fujita et al.
35
 3 mmol 
Nucleoside was added to chilled phosphorus oxychloride and trimethyl phosphate under N2 and 
stirred overnight. The clear solution was neutralized to pH8 and diluted in 1.5 L water and 
loaded onto a Dowex 1x8 (Cl
-
 form).  Nucleotide was eluted with a 500 mL 0 – 0.8 M LiCl 
gradient. BMP typically elutes around 0.4 M LiCl. 
FPLC nucleotide program: 
0.00 conc %B 0.0; 0.00 mL/min 1.00; 0.00 valve.pos 1.1; 0.00 valve.pos 2.6; valve.pos 3.5; 0.00 
port.set 6.1; 0.00 mL/mark 10; 0.00 cm/mL 0.10; 100.00 conc %B 0.0; 600.00 conc %B 100; 
650.00 conc %B 100. 
BMP NMR (D2O, ppm): 6.05 (d,1H), 4.95 (q, 1H), 4.25 (t,1H), 3.81 (m, 1H), 3.72 (q,1H), 
3.58 (q, 1H). 
 
BMP 
1
HNMR spectrum  
3-Deazauridine 5’-monophosphate, 4-deoxy-5-fluorouridine 5’-monophosphate, 4-deoxyuridine 
5’-monophosphate. 6 mmol Base was added to 6.2 mmol trimethylchlorosilane and 30 mmol 
hexamethyldisilizane and refluxed for 1- 2 hours until solution was clear. Excess 
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hexamethyldisilazane was removed by high vacuum rotary evaporation followed by 1 hour under 
vacuum at 60°C.  
The dried crystals were dissolved in dichloroethane and added to 5.5 mmol 1-acetyl-
2,3,5-tribenzoylribofuranose and 6 mmol SnCl4. The flask was purged with nitrogen gas and 
stirred overnight (typically 14 hours). The condensation reaction was worked up with saturated 
sodium bicarbonate and saturated sodium chloride. The organic layer was further purified by 
filtering through Celite layered over a sintered glass frit filter. 4-Deoxy-5-fluoro-1-(2,3,5-
tribenzoyl)uridine was purified with preparative TLC in 3% methanol in dichloromethane.
29
 The 
silica containing nucleoside, which fluoresces a significantly brighter blue than 
tribenzoylribofuranose, was scraped off the plates and extracted with 5% methanol in 
dichloromethane. The organic solvent was removed by rotary evaporation and the protected 
nucleoside was redissolved in methanol. 
Benzoate protecting groups were removed by 0.08 M methoxide in methanol for 2-12 
hours, stirring at 4°C and then neutralized with Dowex AG 50x8 resin (H
+ 
form) to pH 4. 
Methanol was evaporated and the nucleoside was purified by an aqueous work up with ethyl 
acetate, which removed the benzoate ester side product. 
UMP derivative nucleotide were phosphorylated according to a modified procedure by 
Fujita.
35
 The nucleoside was added to 3 mole equivalents of chilled phosphorus oxychloride and 
22 equivalents trimethyl phosphate under inert nitrogen atmosphere and stirred overnight at 4°C. 
The clear solution was neutralized to pH8, diluted in 1 L water, and loaded onto a 500 mL DEAE 
column (HCO3
-
 form). The nucleotide was eluted with a 0-0.5 M triethylammonium bicarbonate 
(pH 8.4) gradient and the fractions containing nucleotide collected. The nucleotide was 
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repeatedly washed with water and rotary-evaporated to remove excess triethylammonium 
bicarbonate. Nucleotides were lyophilized and stored at -20°C. 
3-DeazaUMP NMR (D2O, ppm): 7.63 (d, 1H), 6.04 (d, 1H), 5.99 (q, 1H), 5.48 (d, 1H slowly 
exchanges), 4.19 (m, 2H), 4.08 (m, 1H), 3.8-3.9 (m, 2H).  
 
3-DeazaUMP 
1
HNMR spectrum 
5-Fluoro-4-deoxyUMP NMR (D2O, ppm): 8.56 (d, 1H), 8.48 (t, 1H) 5.72 (s, 1H), 4.50 (m, 1H), 
4.14 (m, 1H), 3.98 (q, 2H).  
4-DeoxyUMP NMR (D2O, ppm): 8.6(q, 1H), 8.4 (q, 1H), 6.6 (q, 1H), 5.8 (d, 1H), 4.1 (m, 3H), 
4.0 (q, 1H), 3.8 (q, 1H). 
 
4-DeoxyUMP 
1
HNMR spectrum  
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DihydroOMP Synthesis. DihydroOMP was synthesized according to Chan et al. 20mg (0.1µmol) 
OMP was dissolved in 6 mL 50% aqueous methanol. The reaction was catalyzed by13 mg of 
5% palladium over activated carbon and pressurized with 40 psi hydrogen gas for 24-48 hours at 
room temperature. The catalyst was removed by filtering through Celite over a coarse fritted 
filter and washed with water. The product was lyophilized to dryness and stored at -20°C. 
 
FUMP and OMP Synthesis. FUMP was synthesized according to a modified procedure by Fujita 
et al.
35
 1.9 mmol 5-Fluorouridine (purchased from Sigma Aldrich) was added to chilled 
phosphorus oxychloride and trimethyl phosphate under N2 and stirred overnight. The clear 
solution was neutralized to pH8, diluted in 1 L water, and loaded onto a 500 mL DEAE column 
(HCO3
-
 form). The nucleotide was eluted with a 0-0.5 M triethylammonium bicarbonate (pH 8.4) 
gradient and the fractions containing FUMP collected. Repeated water washes and rotary 
evaporations were remove excess triethylammonium bicarbonate from FUMP fractions.  
 OMP was synthesized with 1-phosphoribosylpyrophosphate and orotate, which were 
purchased from Sigma Aldrich, using OPRTase according to a procedure from Kui Chan’s 
thesis. 
 
Decarboxylation Assay: Initial Rates. The rate of decarboxylation, Vmax, was monitored 
spectrophotometrically on a Perkin Elmer Lambda 14 UV/Vis spectrophotometer at 279 nm with 
increasing substrate concentration until saturation. The Michaelis-Menton constant, KM, was 
calculated as the substrate concentration at half the maximal velocity. Because the substrate 
OMP, product UMP and the enzyme absorb at 279 nm, the assay wavelength and Δε were 
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adjusted at OMP concentration greater than 120 µM to prevent absorbance values greater than 1 
(Appendix 5.2.2). 
 
Decarboxylation Assay: First Order Decay. The rate of decarboxylation, Vmax, for enzymes 
exhibiting wildtype-like kinetics was measured spectrophotometrically at 279 nm (ε = 2400 M-1) 
by saturating the enzyme with OMP amounts greater than 10-fold the KM value. The KM values 
of OMPDC are approximately 1.5 µM, which cannot be accurately quantitated by initial 
velocities; KM values were measured by the first order decay of the OMPDC reaction, wherein 
the change in absorbance over time, at substrate concentrations ≤ 20 % of the estimated KM, was 
fitted to the following first order decay equation  
A = Af + (Ai – Af)e-kt 
where t is time, A is the absorbance at time t, Af is the absorbance after reaction completion, Ai 
is the calculated initial absorbance, and k is the first order rate constant equal to Vmax/ KM. The 
amount of OMP added to the assay was calculated to ensure saturation, however, the product 
UMP introduces a small amount of error as it has a Ki of 170 µM. Therefore OMP 
concentrations greater than 10-fold KM were not applied to first order decay assays. 
 
Exchange Assay. Exchange of the H6 proton of FUMP was measured by the rate of incorporation 
of solvent-derived deuterium. FUMP (triethylammonium salt) was lyophilized to dryness and 
resuspended in deuterium oxide. The concentration of FUMP was determined at 269 nm     
(ε=9200). The rate of deuterium incorporation was observed at 25°C by pre-acquisition decay 
array by NMR with 150 transients (20 minutes) per timepoint, a sweep width of 950 Hz, a 
relaxation time of 2 microseconds, and an acquisition time of 6 microseconds. 
19
F-NMR shows 
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well-resolved peaks for protonated FUMP (hFUMP, doublet of doublets) and deuterated FUMP 
(dFUMP, doublet) shifted downfield by 0.28 ppm. A typical exchange reaction with 0.5 mg/mL 
wildtype OMPDC enzyme exchanges approximately 50% of 5 mM FUMP in 3 hours. Enzyme 
stored in protonated solvents were washed with buffered deuterium oxide in 150 uL Amicon 
centrifuge tubes with a 10,000 Da molecular weight filter. The exchange reaction was performed 
at 25 C in deuterium oxide buffered with 100 mM glycylglycine (pD 9.35) solution that 
maintained an ionic strength of 0.1 M with NaCl.  
 
Representative H6 exchange reaction in D2O. hFUMP, the doublet of doublets at -163.37 ppm, is 
exchanged to dFUMP, the doublet at -163.65 ppm. 
 
The exchange rate was measured by comparing the integration of hFUMP to the 
combined integration of hFUMP and dFUMP and plotted against time. The observed exchange 
rate, kobs, was given by the negative slope of the linear fitted line and the exchange rate, kex, was 
calculated by 
kex = kobs[total FUMP]/[OMPDC] 
where [hFUMP + dFUMP] is the total FUMP concentration and [OMPDC] is the total enzyme 
concentration. 
6-AzaUMP, 3-DeazaUMP, UMP, 4-Deoxy-5-fluoroUMP Inhibition. Inhibition constants were 
measured by first order decay with inhibitor concentrations, which yields the apparent Michaelis-
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Menton constants, KM’. The range of inhibitor concentrations was taken close to the Ki values 
thus, azaUMP concentrations were between 0.1 and 30 µM while 3-deazaUMP and UMP were 
measured between 10 and 120 µM. However, as inhibitors absorb at 279 nm, inhibitor 
concentrations greater than 150 µM had poor signal to noise. Thus, the inhibition of DFUMP 
could not be measured as it exceeded the range of the assay. The slope of equation 
KM’ = KM (1 + [I] / Ki) 
is KM/Ki, where [I] is the inhibitor concentration, and which yields the inhibition constant, Ki. 
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APPENDIX A: EXTINCTION COEFFICIENTS 
 
Nucleotide extinction coefficients ε at wavelength λmax 
 
Nucleotide ε (extinction coefficient, M-1cm-1) λ (nm) 
Orotidine 5’-monophosphate 9430 267 
Uridine 5’-monophosphate 10000 262 
5-Fluorouridine 5’-monophosphate 8000 265 
5-Fluoro-4-deoxyuridine 5’-
monophosphate 
1720 325 
3-Deazauridine 5’-monophosphate36 4260 278 
Barbiturate 5’-monophosphate 19700 260 
Enzyme ε (extinction coefficient, M-1cm-1) λ (nM) 
OMPDC 6085 280 
 
 
Extinction coefficients and relative absorbance changes for OMP decarboxylation at pH 7.1 
 
λ (nm) 
Δε at 25°C  
(M-1s-1) 
AbsOMP relative 
to 279 nm 
Δε for reaction  
relative to 279 nm 
290 1620 0.31 0.68 
289 1775 0.36 0.74 
288 1917 0.40 0.80 
287 2048 0.46 0.85 
286 2158 0.51 0.90 
285 2244 0.57 0.94 
284 2311 0.64 0.96 
283 2358 0.70 0.98 
282 2386 0.78 0.99 
281 2402 0.85 1.00 
280 2409 0.92 1.00 
279 2400 1.00 1.00 
278 2375 1.08 0.99 
277 2327 1.15 0.97 
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APPENDIX B: PRIMERS, GENE AND PROTEIN SEQUENCES 
 
Primer sequences list 
 
Primer Sequence 
GerltT7pro CCCGCGAAATTAATACGACTCACTATAGGGG 
GerltT7term CAAGGGGTTATGCTAGTTATTGCTCAGCGG 
S127P_f CCTCCTGACAGAGATGCCACACCCAGGG 
S127P_r CCCTGGGTGTGGCATCTCTGTCAGGAGG 
S127G_f CCTCCTGACAGAGATGGGACACCCAGGG 
S127G_r CCCTGGGTGTCCCATCTCTGTCAGGAGG 
S127A_f CCTCCTGACAGAGATGGCACACCCGGGGGCAG 
S127A_r CTGCCCCCGGGTGTGCCATCTCTGTCAGGAGG 
V155I_f GGGTCGATCTTGGTGTCAAAAATTATATTGGCCCATCCACAAGACC 
V155I_r GGTCTTGTGGATGGGCCAATATAATTTTTGACACCAAGATCGACCC 
V155F_f GGGTCGATCTTGGTGTCAAAAATTATTTTGGCCCATCCACAAGACC 
V155F_r GGTCTTGTGGATGGGCCAAAATAATTTTTGACACCAAGATCGACCC 
V155S_f GGGGTCGATCTTGGTGTCAAAAATTATTCTGGCCCATCCACAAGACC 
V155S_r GGTCTTGTGGATGGGCCAGAATAATTTTTGACACCAAGATCGACCCC 
V155D_f GGGGTCGATCTTGGTGTCAAAAATTATGATGGCCCATCCACAAGACC 
V155D_r GGTCTTGTGGATGGGCCATCATAATTTTTGACACCAAGATCGACCCC 
I96L_f GGCGGGGGCTGATGCCATACTAGTCCACGGATTCCCGGG 
I96L_r CCCGGGAATCCGTGGACTAGTATGGCATCAGCCCCCGCC 
I96F_f GGCGGGGGCTGATGCCATATTTGTCCACGGATTCCCGGG 
I96F_r CCCGGGAATCCGTGGACAAATATGGCATCAGCCCCCGCC 
I96S_f GGCGGGGGCTGATGCCATAAGCGTCCACGGATTCCCGGG 
I96S_r CCCGGGAATCCGTGGACGCTTATGGCATCAGCCCCCGCC 
I96T_f GGCGGGGGCTGATGCCATAACAGTCCACGGATTCCCGGG 
I96T_r CCCGGGAATCCGTGGACTGTTATGGCATCAGCCCCCGCC 
L123N_f GGGACGTGAGGTCTTCCTCAACACAGAGATGTCACACCCGGGG 
L123N_r CCCCGGGTGTGACATCTCTGTGTTGAGGAAGACCTCACGTCCC 
L123S_f GGGACGTGAGGTCTTCCTCTCGACAGAGATGTCACACCCGGGG 
L123S_r CCCCGGGTGTGACATCTCTGTCGAGAGGAAGACCTCACGTCCC 
I200F_f CGCAGATGCCATATTTGTTGGAAGATCCATCTACCTTGCAGATAACCC 
I200F_r GGGTTATCTGCAAGGTAGATGGATCTTCCAACAAATATGGCATCTGCG 
D70A_f GGCTGCAGAATCATAGCCGCCTTCAAGGTTGCAG 
D70A_r CTGCAACCTTGAAGGCGGCTATGATTCTGCAGCC 
D70N_f GGCTGCAGAATCATAGCCAATTTCAAGGTTGCAG 
D70N_r CTGCAACCTTGAAATTGGCTATGATTCTGCAGCC 
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Gene and Protein Sequences 
 
OMPDC DNA sequence 
 
ATGAGATCCCGGAGAGTTGATGTTATGGACGTTATGAACAGACTTATACTTGCAATG
GACCTCATGAACCGGGATGATGCCCTCAGGGTCACCGGAGAGGTCAGGGAATACAT
AGACACGGTCAAGATAGGGTACCCCCTTGTACTCTCAGAGGGTATGGATATCATTGC
TGAGTTCAGAAAGAGATTTGGCTGCAGAATCATAGCCGACTTCAAGGTTGCAGATAT
ACCCGAGACCAATGAAAAGATATGCCGGGCCACCTTCAAGGCGGGGGCTGATGCCA
TAATAGTCCACGGATTCCCGGGAGCAGACAGTGTCAGGGCCTGCCTCAATGTCGCA
GAGGAAATGGGACGTGAGGTCTTCCTCCTGACAGAGATGTCACACCCGGGGGCAGA
GATGTTCATACAGGGCGCTGCAGATGAAATAGCCAGAATGGGGGTCGATCTTGGTG
TCAAAAATTATGTTGGCCCATCCACAAGACCTGAAAGGCTTTCAAGGCTGAGGGAA
ATCATAGGTCAGGATTCATTTCTCATATCCCCCGGTGTGGGAGCCCAGGGAGGAGAC
CCAGGGGAGACCCTCAGGTTCGCAGATGCCATAATAGTTGGAAGATCCATCTACCTT
GCAGATAACCCTGCAGCTGCAGCAGCAGGGATAATAGAATCCATTAAAGACCTTCT
GAATCCCTAA 
 
OMPDC protein sequence 
 
MRSRRVDVMDVMNRLILAMDLMNRDDALRVTGEVREYIDTVKIGYPLVLSEGMDIIAE
FRKRFGCRIIADFKVADIPETNEKICRATFKAGADAIIVHGFPGADSVRACLNVAEEMGR
EVFLLTEMSHPGAEMFIQGAADEIARMGVDLGVKNYVGPSTRPERLSRLREIIGQDSFLIS
PGVGAQGGDPGETLRFADAIIVGRSIYLADNPAAAAAGIIESIKDLLNP* 
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APPENDIX C: BUFFERS AND AKTA PROGRAMS 
 
Buffers for Nickel Affinity Chromotography 
 
1x Binding Buffer: 5 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl (pH 7.9), 5 mM Mg2Cl. 
1x Wash Buffer: 60 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl (pH 7.9), 5 mM Mg2Cl. 
1x Elute Buffer: 1 M imidazole, 500 mM NaCl, 20 mM Tris-HCl (pH 7.9), 5 mM Mg2Cl 
1x Charge Buffer: 50 mM NiSO4. 
1x Strip Buffer: 100 mM EDTA, 500 mM NaCl, 20 mM Tris-HCl (pH 7.9). 
 
AKTA FPLC Program: Nickel Affinity Chromotography 
 
Resin: Chelating Sepharose Fast Flow (GE Healthcare; 17 0575-01) 
Approximate volume: 100 mL 
 
 Load Sample 
 Flow 3 mL/min 
 
 Wash Unbound Sample 
 Flow 4 mL/min 
 0-300 1x binding 
 300-600 5% 1x elution, 95% 1x wash 
 600-750 1x binding 
 
 Gradient Elution 
 Flow 4 mL/min 
 Fraction size 10 mL 
 750-1200 100% 1x wash – 100% 1x elution 
 
 Clean and Regenerate Column 
 1200-1450 1x strip 
 1450-1800 water 
 1800-2000 1 M NaCl 
 2000-2050 water 
 2050-2500 1 M NaOH 
 2500-2550 water 
 2550-2750 50% aqueous ethanol 
 2750-2825 water 
 2825-3125 1x charge 
 3125-3425 1x binding 
 
Buffers for Strong Anion Exchange (Q Sepharose) Chromatography, Thrombin Cleavage, and 
Storage 
 
1x Phosphate Buffered Solution: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM, 
KH2HPO4. 
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1x High Salt Buffer: 1 M NaCl, 20 mM Tris-HCl (pH 7.9). 
1x Low Salt Buffer: 20 mM Tris-HCl (pH 7.9). 
1x Storage Buffer: 150 mM NaCl, 20 mM HEPES (pH 7.5), ±3 mM DTT. 
 
AKTA FPLC Program: Strong Anion Exchange Chromatography 
 
Resin: Chelating Sepharose Fast Flow (GE Healthcare; 17 0575-01) 
Approximate volume: 100 mL 
 
 Load Sample 
 Flow 3 mL/min 
 
 Wash Unbound Sample 
 Flow 2 mL/min 
 0-135 1x low salt buffer 
 
 Gradient Elution 
 Flow 
 Fraction size 
135-885 100% 1x low salt – 100% 1x high salt 
  
 Clean and Regenerate Column 
 Flow 2 mL/min 
 885-950 Water 
 950-1150 1 M NaOH 
 1150-1250 Water 
 1250-1350 50% aqueous ethanol 
 1350-1450 Water 
 1450-1650 1 M NaCl 
 1650-1850 1x low salt 
 
